129 related articles for article (PubMed ID: 9871603)
1. Nonpeptide glycoprotein IIb/IIIa inhibitors: substituted quinazolinediones and quinazolinones as potent fibrinogen receptor antagonists.
Liverton NJ; Armstrong DJ; Claremon DA; Remy DC; Baldwin JJ; Lynch RJ; Zhang G; Gould RJ
Bioorg Med Chem Lett; 1998 Mar; 8(5):483-6. PubMed ID: 9871603
[TBL] [Abstract][Full Text] [Related]
2. Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 3: synthesis and SAR of potent and specific 2,8-diazaspiro[4.5]decanes.
Mehrotra MM; Heath JA; Rose JW; Smyth MS; Seroogy J; Volkots DL; Ruhter G; Schotten T; Alaimo L; Park G; Pandey A; Scarborough RM
Bioorg Med Chem Lett; 2002 Apr; 12(7):1103-7. PubMed ID: 11909727
[TBL] [Abstract][Full Text] [Related]
3. Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 1: design of potent and specific 3,9-diazaspiro[5.5]undecanes.
Smyth MS; Rose J; Mehrotra MM; Heath J; Ruhter G; Schotten T; Seroogy J; Volkots D; Pandey A; Scarborough RM
Bioorg Med Chem Lett; 2001 May; 11(10):1289-92. PubMed ID: 11392539
[TBL] [Abstract][Full Text] [Related]
4. Spirocyclic nonpeptide glycoprotein IIb-IIIa antagonists. Part 2: design of potent antagonists containing the 3-azaspiro[5.5]undecanes.
Pandey A; Seroogy J; Volkots D; Smyth MS; Rose J; Mehrotra MM; Heath J; Ruhter G; Schotten T; Scarborough RM
Bioorg Med Chem Lett; 2001 May; 11(10):1293-6. PubMed ID: 11392540
[TBL] [Abstract][Full Text] [Related]
5. Platelet glycoprotein IIb/IIIa receptor antagonists derived from isoxazolidines.
Confalone PN; Jin F; Mousa SA
Bioorg Med Chem Lett; 1999 Jan; 9(1):55-8. PubMed ID: 9990456
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and molecular docking studies of 2-piperazin-1-yl-quinazolines as platelet aggregation inhibitors and ligands of integrin αIIbβ3.
Krysko AA; Kornylov AY; Polishchuk PG; Samoylenko GV; Krysko OL; Kabanova TA; Kravtsov VCh; Kabanov VM; Wicher B; Andronati SA
Bioorg Med Chem Lett; 2016 Apr; 26(7):1839-43. PubMed ID: 26912112
[TBL] [Abstract][Full Text] [Related]
7. Peptidomimetics - antagonists of the fibrinogen receptors: molecular design, structures, properties and therapeutic applications.
Andronati SA; Karaseva TL; Krysko AA
Curr Med Chem; 2004 May; 11(9):1183-211. PubMed ID: 15134514
[TBL] [Abstract][Full Text] [Related]
8. Use of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists.
Sall DJ; Arfsten AE; Bastian JA; Denney ML; Harms CS; McCowan JR; Morin JM; Rose JW; Scarborough RM; Smyth MS; Um SL; Utterback BG; Vasileff RT; Wikel JH; Wyss VL; Jakubowski JA
J Med Chem; 1997 Aug; 40(18):2843-57. PubMed ID: 9288166
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacology of modified amidine isoxazoline glycoprotein IIb/IIIa receptor antagonists.
Sielecki TM; Liu J; Mousa SA; Racanelli AL; Hausner EA; Wexler RR; Olson RE
Bioorg Med Chem Lett; 2001 Aug; 11(16):2201-4. PubMed ID: 11514170
[TBL] [Abstract][Full Text] [Related]
10. Novel non-peptide fibrinogen receptor antagonists. 1. Synthesis and glycoprotein IIb-IIIa antagonistic activities of 1,3,4-trisubstituted 2-oxopiperazine derivatives incorporating side-chain functions of the RGDF peptide.
Sugihara H; Fukushi H; Miyawaki T; Imai Y; Terashita Z; Kawamura M; Fujisawa Y; Kita S
J Med Chem; 1998 Feb; 41(4):489-502. PubMed ID: 9484499
[TBL] [Abstract][Full Text] [Related]
11. Progress in the research of GPIIb/IIIa antagonists.
Xie Z; Cao C; Feng S; Huang J; Li Z
Future Med Chem; 2015; 7(9):1149-71. PubMed ID: 26132524
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors.
Grumel V; Mérour JY; Lesur B; Giboulot T; Frydman A; Guillaumet G
Eur J Med Chem; 2002 Jan; 37(1):45-62. PubMed ID: 11841874
[TBL] [Abstract][Full Text] [Related]
13. New platelet fibrinogen receptor glycoprotein IIb-IIIa antagonists: orally active series of N-alkylated amidines with a 6,6-bicyclic template.
Okumura K; Shimazaki T; Aoki Y; Yamashita H; Tanaka E; Banba S; Yazawa K; Kibayashi K; Banno H
J Med Chem; 1998 Oct; 41(21):4036-52. PubMed ID: 9767641
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and properties of peptidomimetics--inhibitors of platelet aggregation.
Andronati SA; Krysko AA; Kabanov VM; Karaseva TL; Kabanova TA
Acta Pol Pharm; 2000 Nov; 57 Suppl():15-21. PubMed ID: 11293251
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel antagonists of glycoprotein IIb/IIIa-mediated platelet aggregation through virtual screening.
Wang Y; Zhao Y; Sun R; Kong W; Wang B; Yang G; Li Y
Bioorg Med Chem Lett; 2015 Mar; 25(6):1249-53. PubMed ID: 25677660
[TBL] [Abstract][Full Text] [Related]
16. Dissociation of glycoprotein IIb/IIIa antagonists from platelets does not result in fibrinogen binding or platelet aggregation.
Frelinger AL; Furman MI; Krueger LA; Barnard MR; Michelson AD
Circulation; 2001 Sep; 104(12):1374-9. PubMed ID: 11560852
[TBL] [Abstract][Full Text] [Related]
17. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antiplatelet effects of an isoxazole series of glycoprotein IIb/IIIa antagonists.
Xue CB; Roderick J; Mousa S; Olson RE; DeGrado WF
Bioorg Med Chem Lett; 1998 Dec; 8(24):3499-504. PubMed ID: 9934460
[TBL] [Abstract][Full Text] [Related]
19. The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor.
Tsikaris V
J Pept Sci; 2004 Oct; 10(10):589-602. PubMed ID: 15526708
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa receptor-directed platelet inhibition.
Li YF; Spencer FA; Becker RC
Am Heart J; 2002 Apr; 143(4):725-32. PubMed ID: 11923812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
